Windyga, J., Timofeeva, M., Stasyshyn, O., Mamonov, V., Lamas Castellanos, J. L., Lissitchkov, T., . . . Tangada, S. (2020). Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B. Clin Appl Thromb Hemost.
Citação norma ChicagoWindyga, Jerzy, et al. "Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B." Clin Appl Thromb Hemost 2020.
MLA CitationWindyga, Jerzy, et al. "Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B." Clin Appl Thromb Hemost 2020.